
Headquartered in Boston, the intellectual property transactions services team at Goodwin advises early-stage companies, established businesses, and academic institutions in establishing licensing frameworks, collaboration agreements, and business transactions. The intellectual property group is co-chaired by Boston-based Catherine McCarthy, who represents public and private companies, as well as venture capital partnerships in the pharmaceutical, life sciences, and technology industries, and Silicon Valley-based James Riley, who strategizes with emerging technology companies on licensing, commercialization, and investments. Other key members of the team include Boston-based life sciences co-chair Kingsley Taft, who focuses on commercial transactions, M&A, and IPOs, and DC-based Noelle Dubiansky, who offers strategic licensing and transactional advice to biotechnology, pharmaceutical, and medical device clients.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
‘Patent licensing is a crucial aspect of our business and demands that we have strong technical advisors with extensive commercial deal expertise. Our Goodwin team blends these two areas extremely well. They are top-tier in these areas.
- 'They communicate responsively, and I trust that they will vigorously represent our interests. They also leverage generative AI technologies to assist their reviews.’
‘Technical acumen and commercial expertise. Our team wears both hats incredibly well and provides well-reasoned and solution-oriented counsel.’
Key clients
- Fox Robotics
- General Catalyst and Kleiner Perkins
- Zealand Pharma
- Deep Apple Therapeutics
- Syneron Bio
- Kymera Therapeutics
- Orionis Biosciences
- Gubra
- ProFound Therapeutics
- Freenome
- Harbour BioMed
- Sichuan Kelun Biotech Pharmaceutical
Work highlights
Advised Zealand Pharma A/S on its collaboration with F. Hoffmann-La Roche AG on the largest ever single asset partnership deal worth up to $5.3 billion
Advised Kleiner Perkins and General Catalyst in the $2.4 billion license and hire transaction with Google involving their portfolio company, Windsurf.
Advised Orionis Biosciences on their second multi-year collaboration with Genentech for up to $2 billion.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head
Catherine McCarty; James Riley
Other key lawyers
Kingsley Taft; Noelle Dubiansky; Sarah Solomon; Stephen Charkoudian; Bethany Withers; Erini Svokos
